Loading…
Novel organophosphorus aminopyrimidines as unique structural DNA-targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus
A series of novel unique structural organophosphorus aminopyrimidines were developed as potential DNA-targeting membrane active inhibitors through an efficient one-pot procedure from aldehydes, phosphonate and aminopyrimidine. The biological assay revealed that some of the prepared compounds display...
Saved in:
Published in: | MedChemComm 2018-09, Vol.9 (9), p.1529-1537 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of novel unique structural organophosphorus aminopyrimidines were developed as potential DNA-targeting membrane active inhibitors through an efficient one-pot procedure from aldehydes, phosphonate and aminopyrimidine. The biological assay revealed that some of the prepared compounds displayed antibacterial activities. In particular, imidazole derivative
exhibited more potent inhibitory activity against MRSA with an MIC value of 4 μg mL
in comparison with the clinical drugs chloromycin and norfloxacin. Experiments revealed that the active molecule
had the ability to rapidly kill the tested strains without obviously triggering the development of bacterial resistance, showed low toxicity to L929 cells and could disturb the cell membrane. The molecular docking study discovered that compound
could bind with DNA gyrase
hydrogen bonds and other weak interactions. Further exploration disclosed that the active molecule
could also effectively intercalate into MRSA DNA and form a steady
-DNA supramolecular complex, which might further block DNA replication to exert powerful antibacterial effects. |
---|---|
ISSN: | 2040-2503 2040-2511 |
DOI: | 10.1039/c8md00301g |